16 December 2021 | News
To open new chapter of domestically-made MRI-conditional pacemakers
LifeTech Scientific Corporation has extended its agreements with Medtronic to further the strategic collaboration on the "HeartTone™ domestic pacemaker project" and to start the collaboration on domestically-made MRI-conditional pacemakers.
Together with MRI-conditional leads, these products will address growing MRI-related therapeutic needs in China.
The agreements also include the extension of the partnership on the "HeartTone™ domestic pacemaker project" to 2028. Similar to its collaboration on the first generation of HeartTone™ pacemakers, Medtronic will provide a series of specialized technical consulting services for the MRI-conditional products project.
LifeTech began its strategic relationship with Medtronic, Inc. in pacemaker product development since 2014. In December 2017, LifeTech's HeartTone™ brand implantable cardiac pacemakers were successfully launched in the Chinese market with accompanying leads and programmers, providing a complete resolution for China patients. This latest collaboration will further meet the fast-growing demand for MRI-conditional cardiac pacing therapies in China, benefiting patients who suffer from bradycardia.